Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 115.06 CHF 0.63% Market Closed
Market Cap: 220.8B CHF

Profitability Summary

Novartis AG's profitability score is 73/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

73/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

73/100
Profitability
Score
73/100
Profitability
Score

Margins

Earnings Waterfall
Novartis AG

Margins Comparison
Novartis AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.9B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.6B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
111.6B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.6B GBP
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Novartis AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.9B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
111.6B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.6B GBP
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Novartis AG

Last Value
3-Years Average
FCF Margin
Conversion Rate